HSBC Upgrades AbbVie (ABBV) to Buy, Raises Price Target to $265

AbbVie Inc. (NYSE:ABBV) is included among the 15 Best Stocks to Buy for the Long Term. HSBC Upgrades AbbVie (ABBV) to Buy, Raises Price Target to $265 Photo by nathan dumlao on Unsplash On December 10, HSBC increased its price target on AbbVie Inc. (NYSE:ABBV) from $225 to $265 and also upgraded the stock to Buy. Previously, on November 5, Piper Sandler reiterated a Buy rating on ABBV with a $289 price target, which reflects a 29.6% upside from its current levels. Over the years, AbbVie Inc. (NYSE:ABB ...